| Product NDC: | 0781-5184 |
| Proprietary Name: | Levothyroxine sodium |
| Non Proprietary Name: | Levothyroxine sodium |
| Active Ingredient(s): | 100 ug/1 & nbsp; Levothyroxine sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-5184 |
| Labeler Name: | Sandoz Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021342 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020301 |
| Package NDC: | 0781-5184-10 |
| Package Description: | 1000 TABLET in 1 BOTTLE (0781-5184-10) |
| NDC Code | 0781-5184-10 |
| Proprietary Name | Levothyroxine sodium |
| Package Description | 1000 TABLET in 1 BOTTLE (0781-5184-10) |
| Product NDC | 0781-5184 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levothyroxine sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020301 |
| Marketing Category Name | NDA |
| Labeler Name | Sandoz Inc. |
| Substance Name | LEVOTHYROXINE SODIUM |
| Strength Number | 100 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] |